Koyfin Home > Directory > Health Care > Arena Pharmaceuticals > Total Debt / Equity

Arena Pharmaceuticals Total Debt / Equity Chart (ARNA)

Arena Pharmaceuticals annual/quarterly Total Debt / Equity from 2000 to 2018. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Arena Pharmaceuticals Total Debt / Equity for the quarter ending September 09, 2018 was $11m a -165.14% decrease of -19m year over year
  • Arena Pharmaceuticals Total Debt / Equity for the last 12 months ending September 09, 2018 was $11m a -165.14% decrease of -19m year over year
  • Arena Pharmaceuticals Annual Total Debt / Equity for 2017 was $30m a -442.01% decrease of -132m from 2016
  • Arena Pharmaceuticals Annual Total Debt / Equity for 2016 was $162m a 21.11% increase of 34m from 2015
  • Arena Pharmaceuticals Annual Total Debt / Equity for 2015 was $127m a -17.22% decrease of -22m from 2014
Other Ratios Metrics:
  • Arena Pharmaceuticals Total Debt / Capital for the quarter ending September 09, 2018 was $10m a -127.22% decrease of -13m year over year
  • Arena Pharmaceuticals Other Liabilities for the quarter ending September 09, 2018 was $1m a -69.22% decrease of -1m year over year
View Chart On Koyfin

Quarterly ARNA Total Debt / Equity Data

09/2018$11m
06/2018$11m
03/2018$11m
12/2017$30m
09/2017$29m
06/2017$77m
03/2017$242m
12/2016$162m
09/2016$1,620m
06/2016$493m

Annual ARNA Total Debt / Equity Data

2017$30m
2016$162m
2015$127m
2014$149m
2013$79m
2012$75m
2011$857m
2010$157m
2009$186m
2008$61m